$ACH Cashflow Statement | Understand Stock

$ACH

$0.20 +$0.00 (0.1%) Close

$ACH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Loss from discontinued operations, net of tax
Adjustments to reconcile net loss to cash (used for) provided by operating activities:
Depreciation and amortization
Share-based compensation expense
Impairment charges
Loss on divestiture
Loss (gain) on extinguishment of debt
Deferred income tax benefit
(Benefit) provision for losses on accounts receivable
Changes in operating lease right-of-use assets and lease liabilities
Gain from sale and dispositions of patient service equipment
Changes in operating assets and liabilities:
Accounts receivable, net
Inventories
Accounts payable
Net change in other assets and liabilities
Other, net

Cash provided by operating activities
Cash (used for) provided by operating activities from discontinued operations
Cash (used for) provided by operating activities
Investing activities:
Proceeds from P&HS sale
Cash sold with P&HS sale
Proceeds from divestiture
Additions to patient service equipment and other fixed assets
Proceeds from sale of patient service equipment
Additions to computer software
Other, net
Cash used for investing activities from discontinued operations
Cash provided by (used for) investing activities

Financing activities:
Borrowings under amended Receivables Financing Agreement
Repayments under amended Receivables Financing Agreement
Borrowings under Revolving Credit Facility
Repayments under Revolving Credit Facility
Repayments of debt
Proceeds from issuance of debt
Proceeds from issuance of common stock
Borrowings under Receivables Financing Agreement
Financing costs paid
Cash dividends paid
Senior Notes make-whole premium paid
Payment for termination of interest rate swaps
Repurchase of common stock
Other, net
Cash used for financing activities from discontinued operations
Cash provided by (used for) financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of cash flow information:
Income taxes paid, net
Interest paid
Noncash investing activity:
Unpaid purchases of patient service equipment and other fixed assets at end of period

Comments